Benefits
DashboardNot registered yet? Get a free account.
Sign Up
INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED
Leave site?
You're about to leave our website and go to an external link. Are you sure?
Active
Updated: 02 Jan 2024
International Drug Discovery & Clinical Research Private Limited, is an unlisted private company incorporated on 09 November, 2009. It is classified as a private limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 1.00 cr and the total paid-up capital is INR 97.32 lac.
The current status of International Drug Discovery & Clinical Research Private Limited is - Active.
Read more
Buy Dashboard using Credits
Just a Quick Check!
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
Industry
Research and Development
Key Metrics
** All rupee values in INR crores. Based on March 2024 numbers.
Total Revenue
8.9%
8.9%
EBITDA
7.69%
7.69%
Net Profit
-68.97%
-68.97%
Networth
2.15%
2.15%
Borrowings
6.23%
6.23%
Assets
5.07%
5.07%
Gross Margin
5.57
5.57
Operating Margin
-0.31
-0.31
Net Profit Margin
-8.37
-8.37
Return on Equity
-8.01
-8.01
ROCE
-0.76
-0.76
Debt to Equity
0.01
0.01
Sales
Mar 2024
Net worth
Mar 2024
Buy Report or Plans
Dashboards
Popular Plan-
₹ 449
Company dashboard-
Five year financials and ratios
-
Risk analysis
-
Interactive charts
-
View subscriptions
and
buy credits 
MCA Fillings
-
₹ 349
All financials
-
All financials
-
All annual returns
-
MoA and AoA
-
-
₹ 249
1 Year
-
Latest financials
-
Latest annual return
-
MoA and AoA
-
PDF Reports
-
₹ 799
Financial report
-
Five year financials and ratios
-
Shareholding and group structure
-
Litigation and more
-
-
₹ 2999
Due diligence report
-
Everything in financial report
-
Peers and financials
-
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Locations
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Select Tags
Choose Location
Tofler Score
Poor
Fair
Good
Very Good
Excellent
Risk
Severe Risk
- No risks identified
Moderate Risk
- No risks identified
Low Risk
- No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is
dependent on three key factors - Sustainability, Governance, and Growth.
Read more
Financial Highlights
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Margins
Gross margin
Operating margin
Net margin
Balance Sheet
₹
%
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets
Profit & Loss
₹
%
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Revenue from operations
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Ratios
Current ratio
Debt/equity ratio
Charges on assets
As per information available, the company has no registered charges.
People
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ahamed Kabeer Zackriyah | 07271845 | 10 years |
| Director | Vasudevan Vijayalakshmi | 07271851 | 10 years |
Company Network
Expand
Delete
Collapse
See
details
Companies connected through Directors
| Name | Status | Paid up Capital | Common Directors | Address |
|---|
Registered Details
CIN
U73100TG2009PTC065747PAN
-Incorporation
2009, 15.5 yearsCompany Email
vijayalakshmi@iddcr.comPaid up Capital
₹ 97.3 LAuthorised Capital
₹ 1.0 CrAGM
Sep 2019Type
Private
Non-government Company
FAQ - INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED
What is the incorporation date of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED?
The incorporation date of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED is 09 November, 2009
What is the authorized share capital of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED?
The authorized share capital of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED is INR ₹ 1.0 Cr.
What is the paid-up capital of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED?
The paid-up capital of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED is INR ₹ 97.3 L.
What is the registered address of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED?
The registered address of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED is H.No.#8-2-293/82/J/A/105, Plot No.105A Journalist Colony,Jubilee Hills Hyderabad Hyderabad Telangana - 500033
What is the CIN number of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED?
The CIN number of INTERNATIONAL DRUG DISCOVERY & CLINICAL RESEARCH PRIVATE LIMITED is U73100TG2009PTC065747.
Smart Suggestions
- Top Security Companies In India
- Highest Tax Paying Companies
- Best Matrimonial Sites
- Top Seed Companies In India
- Fortune 500 Companies In India
- ITC Products List
- Hindustan Unilever Products List
- Top Fan Brands
- Top Indian Companies By Revenue
- How To Check Directors Of A Company
- Automobile Parts Manufacturing Companies In India
- Forging Companies In India
- List Of Government Companies
- Road Construction Companies
- Top Engineering Companies
- Largets Banks By Market Cap
- Eyewear Companies In India
- Top Petrochemical Companies
- Manufacturing Companies In Coimbatore
- Medical Equipment Manufacturing Companies
- Top Companies In Odisha
- Financial Companies In India
- Top Mining Companies
- Top 10 Plastic Companies
- Leather Manufacturing Companies
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all
people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR
UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any,
listed on
this page belong to...
Read
More
